Nom du produit:(1S,3S)-N1-methyl-N1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)cyclobutane-1,3-diamine phosphoric acid
IUPAC Name:(1s,3s)-N1-methyl-N1-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}cyclobutane-1,3-diamine; phosphoric acid
- CAS：2413373-20-1
- Formule moléculaire：C11H18N5O4P
- Pureté：95%+
- Numéro de catalogue：CM577769
- Poids moléculaire：315.27
| Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:2413373-20-1
- Formule moléculaire:C11H18N5O4P
- Point de fusion:-
- Code SMILES:OP(O)(O)=O.CN([C@@H]1C[C@H](N)C1)C1=C2C=CNC2=NC=N1
- Densité:
- Numéro de catalogue:CM577769
- Poids moléculaire:315.27
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Pyrrolopyrimidines
- Fusion heterocyclic compounds have various biological activities, such as anticancer, antibacterial, antifungal and anti-inflammatory, and thus have been widely used in the field of medicinal chemistry. Pyrrolopyrimidines are a major class of fused heterocyclic compounds. Compared with single pyrrole and pyrimidine cores, pyrrolopyrimidines have more diverse and effective pharmacological characteristics as fusion scaffolds.
- Cyclobutanes
- The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.
Recherche 
+86 21 5895 0110 
